Entero Healthcare Solutions allots ESOPs, revises director tenure
Entero Healthcare Solutions allotted 1,475 equity shares to an employee under its ESOP 2023 plan, increasing total issued shares to 4,35,23,072. Additionally, the board approved the re-appointment of Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors for a second term of four years from August 25, 2026, subject to shareholder approval.
*this image is generated using AI for illustrative purposes only.
Entero Healthcare Solutions allotted 1,475 equity shares to an eligible employee upon the exercise of options under the Entero Employee Stock Option Plan 2023. The shares, with a face value of Rs. 10 each, were issued at an exercise price of Rs. 804 per share. This issuance increases the company's total issued share capital to Rs. 43,52,30,720 and the total number of issued shares to 4,35,23,072. The shares rank pari-passu with existing equity shares and are not subject to any lock-in period restrictions.
The Board of Directors also approved the revised tenure for the re-appointment of Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma as Non-Executive Independent Directors. The reappointments are for a second term of four consecutive years, commencing on August 25, 2026, and concluding on August 24, 2030. These decisions are subject to the approval of shareholders at the ensuing Annual General Meeting. The tenure of Mr. Sujesh Vasudevan, another Non-Executive Independent Director, remains unchanged.
ESOP Allotment Details
The company disclosed the specifics of the share allotment in compliance with SEBI regulations. The options were exercised based on the recommendations of the Nomination and Remuneration Committee.
| Particulars | Details |
|---|---|
| Scheme Name | Entero Employee Stock Option Plan 2023 |
| Number of Shares Allotted | 1,475 |
| Face Value | Rs. 10 |
| Exercise Price | Rs. 804 per equity share |
| Premium | Rs. 794 per equity share |
| Date of Issue | June 26, 2026 |
| Total Issued Shares Post-Allotment | 4,35,23,072 |
| Total Issued Share Capital Post-Allotment | Rs. 43,52,30,720 |
Independent Director Reappointments
The board approved the reappointment of two independent directors to facilitate effective succession planning and ensure a smoother transition in the board's composition.
| Director | Date of Re-Appointment | Term |
|---|---|---|
| Mr. Rajesh Shashikant Dalal | August 25, 2026 | 2nd term of 4 years (August 25, 2026 to August 24, 2030) |
| Ms. Sandhya Gadkari Sharma | August 25, 2026 | 2nd term of 4 years (August 25, 2026 to August 24, 2030) |
Mr. Rajesh Shashikant Dalal is a healthcare leader with over 35 years of experience, including roles as Managing Director of Johnson & Johnson India. Ms. Sandhya Gadkari Sharma brings over four decades of experience in banking and investment, having previously worked with Mahindra and Mahindra Limited and ICICI Bank Limited.
Historical Stock Returns for Entero Healthcare Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.47% | +6.40% | -12.85% | +22.61% | +3.70% | +2.68% |
How will the company utilize the funds raised from the recent ESOP exercise to drive future growth?
What impact will the increased issued share capital have on existing shareholders' earnings per share?
Are there plans to expand the ESOP pool to retain key talent amid competitive market conditions?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
